Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman's and Bartter's syndromes.

Bertoldi, Giovanni; Ravarotto, Verdiana; Sgarabotto, Luca; Davis, Paul A; Gobbi, Laura; Calò, Lorenzo A

Bertoldi, Giovanni; Ravarotto, Verdiana; Sgarabotto, Luca; Davis, Paul A; Gobbi, Laura; Calò, Lorenzo A.

Affiliation

Bertoldi G; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Ravarotto V; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Sgarabotto L; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Davis PA; Department of Nutrition, University of California, Davis, California, USA.
Gobbi L; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Calò LA; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.

J Intern Med ; 291(4): 522-524, 2022 04.

Article de En | MEDLINE | ID: mdl-34875124

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome de Bartter / Angiotensin-converting enzyme 2 / COVID-19 Limites: Humans Langue: En Journal: J Intern Med Sujet du journal: MEDICINA INTERNA Année: 2022 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google